DENVILLE, N.J., March 17, 2009 (GLOBE NEWSWIRE) -- Lantis Laser Inc. (Pink Sheets:LLSR) (http://www.lantislaser.com) today announced that it has signed an exclusive Agreement for the field of human and animal dentistry with the Regents of the University of California for a light-based technology referred to as "Near-infrared Transillumination Imaging of Early Dental Decay." The technology ("NIR Imaging") is the subject of a PCT patent pending application and was researched and developed over the past five years under the direction of Daniel Fried, PhD, a professor of Biomaterials and Bioengineering in the Department of Preventive and Restorative Dentistry at the University of California, San Francisco, School of Dentistry.
Stan Baron, President & CEO of Lantis said, "NIR Imaging is the perfect technology to integrate with Lantis' OCT Dental Imaging System(tm), currently under development, as it can be used to screen for decay and defects in teeth and OCT can then be used to obtain more detailed microstructural information to aid in diagnostic decisions. We believe that the significant benefits of the integrated system will be very apparent to dentists. NIR and OCT use the same light source so there are obvious pricing economies in a combined system."
Dr. Craig Gimbel, Clinical Director at Lantis added that, "Research clearly indicates that NIR Imaging as a screening modality provides significantly more detailed information, particularly on the occlusal (biting) surfaces, than currently used x-ray, digital or conventional. We have been aware of the benefits of NIR technology for some time and recent advancements in sensor technology now make commercialization possible, at an economic cost. We feel that we have reached the point where the full potential of light-based diagnostic imaging technology can now be exploited to create highly advanced and economical diagnostic imaging modalities for dentistry."
Lantis expects that the NIR Imaging System will be available in 2010 and will be integrated with its OCT Dental Imaging System(tm), as well as being available as a stand-alone system. OCT can generate images of both teeth and gums, while NIR can only be used to image teeth above the bone line. Both modalities will provide chairside, real-time images at a higher resolution than x-ray and images can be stored in the patient digital file. Lantis management foresees that light-based imaging will become the dominant imaging modality in the dental office.
About Lantis Laser
Lantis was formed to commercialize the application of novel technologies in the dental industry. The criteria for selected products include competitive edge, exclusivity and large market potential. Lantis is currently in Phase 2 and Phase 3 development of its OCT product towards deploying beta, clinical use and applying for FDA clearance and plans to launch the OCT Dental Imaging System(TM) in the first quarter of 2010. Lantis has the rights to the application of OCT technology in the field of dentistry under its license Agreements with Lawrence Livermore National Laboratory (exclusive); Lightlab Imaging (non-exclusive) and its development and supply Agreement with AXSUN (exclusive). Lantis also has an exclusive license for the field of dentistry with the Regents of the University of California for NIR Imaging. To find out more about Lantis Laser (Pink Sheets:LLSR), visit www.lantislaser.com
About UCSF School of Dentistry
For 125 years, the UCSF School of Dentistry has improved public health through excellence in teaching, research, patient care and service in the dental and craniofacial sciences. The school's world-renowned faculty provides postgraduate instruction in dental public health, endodontics, oral and maxillofacial surgery, orthodontics and pediatric dentistry, among others. UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. For further information, please visit www.ucsf.edu.
Safe Harbor: Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The company intends that such statements about the Company's future expectations, including future revenues and earnings, technology efficacy and all other forward-looking statements be subject to the safe harbors created thereby. The Company is a development stage company who continues to be dependent upon outside capital to sustain its existence. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results.